Meanwhile, a previous report of Nrf2 as a promising drug target to treat obesity speculated that Nrf2 may be the key factor of antioxidant reaction in testes [18,19]. The gene discussed is NFE2L2; the disease is obesity due to melanocortin 4 receptor deficiency.